Cell-specific	O
expression	O
of	O
helix-loop-helix	B-protein
transcription	I-protein
factors	I-protein
encoded	O
by	O
the	O
E2A	B-DNA
gene	I-DNA
.	O

The	O
E2A	B-DNA
gene	I-DNA
encodes	O
transcription	B-protein
factors	I-protein
of	O
the	O
helix-loop-helix	B-protein
family	I-protein
that	O
are	O
implicated	O
in	O
cell-specific	O
gene	O
expression	O
as	O
part	O
of	O
dimeric	B-protein
complexes	I-protein
that	O
interact	O
with	O
E	B-DNA
box	I-DNA
enhancer	I-DNA
elements	I-DNA
.	O

It	O
has	O
previously	O
been	O
shown	O
that	O
transcripts	O
of	O
the	O
E2A	B-DNA
gene	I-DNA
can	O
be	O
detected	O
in	O
a	O
wide	O
range	O
of	O
cell	O
types	O
.	O

We	O
have	O
now	O
examined	O
expression	O
of	O
the	O
mouse	B-DNA
E2A	I-DNA
gene	I-DNA
at	O
the	O
protein	O
level	O
using	O
polyclonal	O
antisera	O
directed	O
against	O
distinct	O
portions	O
of	O
the	O
E2A	B-protein
protein	I-protein
to	O
probe	O
blots	O
of	O
cellular	O
extracts	O
.	O

A	O
73	B-protein
kDa	I-protein
protein	I-protein
was	O
identified	O
by	O
this	O
analysis	O
:	O
this	O
protein	O
is	O
highly	O
enriched	O
in	O
cell	B-cell_line
lines	I-cell_line
of	I-cell_line
B	I-cell_line
lymphoid	I-cell_line
origin	I-cell_line
as	O
compared	O
to	O
pancreatic	B-cell_type
beta-cells	I-cell_type
and	O
fibroblast	B-cell_type
cells	I-cell_type
.	O

The	O
detection	O
of	O
this	O
protein	O
selectively	O
in	O
extracts	O
of	O
lymphoid	B-cell_type
cells	I-cell_type
correlates	O
with	O
the	O
presence	O
of	O
the	O
E	B-DNA
box	I-DNA
-binding	O
activity	O
LEF1/BCF1	B-protein
in	O
these	O
cells	O
;	O
this	O
binding	O
activity	O
was	O
previously	O
shown	O
to	O
be	O
efficiently	O
recognized	O
by	O
antiserum	O
directed	O
against	O
E2A	B-protein
gene	I-protein
products	I-protein
.	O

Transfection	O
of	O
cells	O
with	O
full	O
length	O
E2A	B-DNA
cDNA	I-DNA
leads	O
to	O
appearance	O
of	O
protein	O
co-migrating	O
with	O
the	O
73	B-protein
kDa	I-protein
protein	I-protein
on	O
SDS	O
gel	O
electrophoresis	O
and	O
co-migrating	O
with	O
LEF1/BCF1	B-protein
on	O
mobility	O
shift	O
analysis	O
.	O

Our	O
results	O
are	O
consistent	O
with	O
the	O
view	O
that	O
the	O
DNA-binding	O
activity	O
LEF1/BCF1	B-protein
is	O
a	O
homodimer	B-protein
of	I-protein
E2A	I-protein
proteins	I-protein
;	O
the	O
selective	O
appearance	O
of	O
this	O
putative	O
cell-specific	O
transcription	O
factor	O
in	O
B	B-cell_type
lymphoid	I-cell_type
cells	I-cell_type
seems	O
to	O
be	O
attributable	O
,	O
at	O
least	O
in	O
part	O
,	O
to	O
the	O
elevated	O
E2A	B-protein
protein	I-protein
concentrations	O
in	O
these	O
cells	O
.	O

Â©	NULL
1993	NULL
Oxford	NULL
University	NULL
Press	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
1601-1606	NULL
Cell-specific	NULL
expression	NULL
of	NULL
helix-loop-helix	NULL
transcription	NULL
factors	NULL
encoded	NULL
by	NULL
the	NULL
E2A	NULL
gene	NULL
Ami	NULL
Aronheim	NULL
,	NULL
Rinat	NULL
Shiran	NULL
,	NULL
Ada	NULL
Rosen	NULL
and	NULL
Michael	NULL
D.Walker*	NULL
Biochemistry	NULL
Department	NULL
,	NULL
Weizmann	NULL
Institute	NULL
of	NULL
Science	NULL
,	NULL
Rehovot	NULL
76100	NULL
,	NULL
Israel	NULL
Received	NULL
January	NULL
4	NULL
,	NULL
1993	NULL
;	NULL
Revised	NULL
and	NULL
Accepted	NULL
February	NULL
26	NULL
,	NULL
1993	NULL
ABSTRACT	NULL
The	NULL
E2A	NULL
gene	NULL
encodes	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
family	NULL
that	NULL
are	NULL
implicated	NULL
in	NULL
cell-specific	NULL
gene	NULL
expression	NULL
as	NULL
part	NULL
of	NULL
dimeric	NULL
complexes	NULL
that	NULL
interact	NULL
with	NULL
E	NULL
box	NULL
enhancer	NULL
elements	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
transcripts	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
have	NULL
now	NULL
examined	NULL
expression	NULL
of	NULL
the	NULL
mouse	NULL
E2A	NULL
gene	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
using	NULL
polyclonal	NULL
antisera	NULL
directed	NULL
against	NULL
distinct	NULL
portions	NULL
of	NULL
the	NULL
E2A	NULL
protein	NULL
to	NULL
probe	NULL
blots	NULL
of	NULL
cellular	NULL
extracts	NULL
.	NULL

A	NULL
73	NULL
kDa	NULL
protein	NULL
was	NULL
identified	NULL
by	NULL
this	NULL
analysis	NULL
:	NULL
this	NULL
protein	NULL
is	NULL
highly	NULL
enriched	NULL
in	NULL
cell	NULL
lines	NULL
of	NULL
B	NULL
lymphoid	NULL
origin	NULL
as	NULL
compared	NULL
to	NULL
pancreatic	NULL
/3-cells	NULL
and	NULL
fibroblast	NULL
cells	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
this	NULL
protein	NULL
selectively	NULL
in	NULL
extracts	NULL
of	NULL
lymphoid	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
E	NULL
box-binding	NULL
activity	NULL
LEF1/BCF1	NULL
in	NULL
these	NULL
cells	NULL
;	NULL
this	NULL
binding	NULL
activity	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
efficiently	NULL
recognized	NULL
by	NULL
antiserum	NULL
directed	NULL
against	NULL
E2A	NULL
gene	NULL
products	NULL
.	NULL

Transfection	NULL
of	NULL
cells	NULL
with	NULL
full	NULL
length	NULL
E2A	NULL
cDNA	NULL
leads	NULL
to	NULL
appearance	NULL
of	NULL
protein	NULL
co-migrating	NULL
with	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
on	NULL
SDS	NULL
gel	NULL
electrophoresis	NULL
and	NULL
co-migrating	NULL
with	NULL
LEF1/BCF1	NULL
on	NULL
mobility	NULL
shift	NULL
analysis	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
view	NULL
that	NULL
the	NULL
DNA-binding	NULL
activity	NULL
LEF1/BCF1	NULL
is	NULL
a	NULL
homodimer	NULL
of	NULL
E2A	NULL
proteins	NULL
;	NULL
the	NULL
selective	NULL
appearance	NULL
of	NULL
this	NULL
putative	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
in	NULL
B	NULL
lymphoid	NULL
cells	NULL
seems	NULL
to	NULL
be	NULL
attributable	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
to	NULL
the	NULL
elevated	NULL
E2A	NULL
protein	NULL
concentrations	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

INTRODUCTION	NULL
E	NULL
boxes	NULL
(	NULL
consensus	NULL
sequence	NULL
CAxxTG	NULL
)	NULL
are	NULL
cis-acting	NULL
DNA	NULL
elements	NULL
important	NULL
for	NULL
transcription	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cell-specifically	NULL
expressed	NULL
genes	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

Proteins	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
(	NULL
HLH	NULL
)	NULL
family	NULL
are	NULL
capable	NULL
of	NULL
sequence-specific	NULL
recognition	NULL
of	NULL
E	NULL
boxes	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
are	NULL
believed	NULL
to	NULL
mediate	NULL
transcriptional	NULL
activation	NULL
in	NULL
vivo	NULL
through	NULL
these	NULL
sequences	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
human	NULL
E2A	NULL
gene	NULL
encodes	NULL
at	NULL
least	NULL
two	NULL
HLH	NULL
proteins	NULL
,	NULL
E12	NULL
and	NULL
E47	NULL
(	NULL
6	NULL
,	NULL
9	NULL
)	NULL
,	NULL
resulting	NULL
from	NULL
alternate	NULL
splicing	NULL
events	NULL
(	NULL
10	NULL
)	NULL
;	NULL
the	NULL
respective	NULL
cDNAs	NULL
were	NULL
originally	NULL
isolated	NULL
by	NULL
expression	NULL
screening	NULL
of	NULL
a	NULL
lymphoid	NULL
library	NULL
using	NULL
a	NULL
DNA	NULL
probe	NULL
corresponding	NULL
to	NULL
xE2	NULL
,	NULL
an	NULL
E	NULL
box	NULL
located	NULL
in	NULL
the	NULL
immunoglobulin	NULL
x	NULL
enhancer	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Corresponding	NULL
E2A	NULL
homologs	NULL
have	NULL
been	NULL
cloned	NULL
from	NULL
rodents	NULL
by	NULL
screening	NULL
of	NULL
pancreatic	NULL
endocrine	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
and	NULL
exocrine	NULL
(	NULL
13	NULL
)	NULL
libraries	NULL
using	NULL
E	NULL
box	NULL
probes	NULL
derived	NULL
from	NULL
the	NULL
control	NULL
regions	NULL
of	NULL
the	NULL
insulin	NULL
and	NULL
chymotrypsin	NULL
genes	NULL
respectively	NULL
.	NULL

E2A	NULL
RNA	NULL
is	NULL
detectable	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
consistent	NULL
with	NULL
a	NULL
broad	NULL
role	NULL
in	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Indeed	NULL
,	NULL
genetic	NULL
evidence	NULL
from	NULL
studies	NULL
of	NULL
daughterless	NULL
(	NULL
da	NULL
)	NULL
,	NULL
the	NULL
presumptive	NULL
Drosophila	NULL
homolog	NULL
of	NULL
the	NULL
EZ2A	NULL
gene	NULL
,	NULL
have	NULL
revealed	NULL
that	NULL
da	NULL
mutations	NULL
lead	NULL
to	NULL
severe	NULL
phenotypes	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
mammalian	NULL
systems	NULL
,	NULL
the	NULL
in	NULL
vivo	NULL
role	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
has	NULL
been	NULL
most	NULL
thoroughly	NULL
explored	NULL
in	NULL
muscle	NULL
cells	NULL
;	NULL
the	NULL
cell-specifically	NULL
expressed	NULL
gene	NULL
MyoD	NULL
(	NULL
16	NULL
)	NULL
and	NULL
its	NULL
close	NULL
relatives	NULL
myogenin	NULL
,	NULL
Myf-5	NULL
and	NULL
MRF4	NULL
(	NULL
17-20	NULL
)	NULL
heterodimerize	NULL
in	NULL
vitro	NULL
with	NULL
E2A	NULL
proteins	NULL
to	NULL
form	NULL
complexes	NULL
that	NULL
bind	NULL
efficiently	NULL
to	NULL
E	NULL
boxes	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Such	NULL
heterodimers	NULL
apparently	NULL
are	NULL
also	NULL
present	NULL
in	NULL
vivo	NULL
:	NULL
antibodies	NULL
directed	NULL
against	NULL
MyoD	NULL
or	NULL
E2A	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
recognize	NULL
muscle	NULL
specific	NULL
E	NULL
box	NULL
binding	NULL
complexes	NULL
using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
analysis	NULL
(	NULL
EMSA	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
fibroblasts	NULL
expressing	NULL
anti-sense	NULL
E2A	NULL
RNA	NULL
showed	NULL
diminished	NULL
ability	NULL
to	NULL
undergo	NULL
MyoD-induced	NULL
differentiation	NULL
,	NULL
underscoring	NULL
the	NULL
importance	NULL
of	NULL
E2A	NULL
proteins	NULL
in	NULL
myogenesis	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
pancreatic	NULL
3	NULL
cells	NULL
,	NULL
E	NULL
boxes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
controlling	NULL
cell-specific	NULL
expression	NULL
of	NULL
the	NULL
insulin	NULL
gene	NULL
(	NULL
3	NULL
,	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Endocrine	NULL
cells	NULL
contain	NULL
a	NULL
nuclear	NULL
complex	NULL
,	NULL
IEF1	NULL
,	NULL
capable	NULL
of	NULL
specific	NULL
E	NULL
box	NULL
recognition	NULL
(	NULL
25-27	NULL
)	NULL
.	NULL

IEF1	NULL
is	NULL
recognized	NULL
by	NULL
antisera	NULL
directed	NULL
against	NULL
EZA	NULL
proteins	NULL
indicating	NULL
that	NULL
these	NULL
proteins	NULL
are	NULL
a	NULL
component	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
12	NULL
,	NULL
27-29	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
HLH	NULL
component	NULL
of	NULL
IEF1	NULL
,	NULL
absent	NULL
from	NULL
non-endocrine	NULL
cells	NULL
,	NULL
has	NULL
been	NULL
defined	NULL
by	NULL
in	NULL
vitro	NULL
mixing	NULL
experiments	NULL
using	NULL
nuclear	NULL
extracts	NULL
and	NULL
in	NULL
vitro	NULL
translated	NULL
HLH	NULL
proteins	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
at	NULL
least	NULL
two	NULL
mammalian	NULL
cell	NULL
types	NULL
,	NULL
functional	NULL
cell-specific	NULL
transcription	NULL
factors	NULL
appear	NULL
to	NULL
be	NULL
generated	NULL
by	NULL
dimerization	NULL
of	NULL
cell-specific	NULL
HLH	NULL
proteins	NULL
with	NULL
apparently	NULL
ubiquitously-expressed	NULL
HLH	NULL
proteins	NULL
,	NULL
the	NULL
E2A	NULL
gene	NULL
products	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
lymphoid	NULL
cells	NULL
,	NULL
a	NULL
cell-specific	NULL
E	NULL
box	NULL
binding	NULL
complex	NULL
(	NULL
LEFI/BCF1	NULL
)	NULL
has	NULL
also	NULL
been	NULL
identified	NULL
(	NULL
27	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
;	NULL
antibody	NULL
experiments	NULL
indicate	NULL
the	NULL
presence	NULL
of	NULL
E2A	NULL
protein	NULL
in	NULL
the	NULL
complex	NULL
,	NULL
yet	NULL
a	NULL
lymphoid-specific	NULL
HLH	NULL
partner	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
current	NULL
evidence	NULL
indicates	NULL
that	NULL
LEF1I/BCF1	NULL
may	NULL
be	NULL
a	NULL
*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
1602	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
homodimer	NULL
of	NULL
E2A	NULL
proteins	NULL
(	NULL
31	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
conclusion	NULL
can	NULL
not	NULL
explain	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
LEFI/BCF1	NULL
complex	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
where	NULL
E2A	NULL
RNA	NULL
is	NULL
present	NULL
.	NULL

To	NULL
further	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
in	NULL
cell-specific	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
used	NULL
two	NULL
types	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
C-terminus	NULL
and	NULL
N-terminus	NULL
region	NULL
of	NULL
E2A	NULL
protein	NULL
,	NULL
to	NULL
investigate	NULL
protein	NULL
levels	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Although	NULL
comparable	NULL
levels	NULL
of	NULL
steady	NULL
state	NULL
RNA	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
multiple	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
lymphoid	NULL
cells	NULL
and	NULL
fibroblasts	NULL
(	NULL
14	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
dramatic	NULL
difference	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
:	NULL
immunoblot	NULL
analysis	NULL
identified	NULL
a	NULL
prominent	NULL
73	NULL
kDa	NULL
protein	NULL
in	NULL
extracts	NULL
of	NULL
B	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
non-lymphoid	NULL
lines	NULL
tested	NULL
(	NULL
at	NULL
least	NULL
15-fold	NULL
lower	NULL
levels	NULL
)	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
a	NULL
product	NULL
of	NULL
the	NULL
E2A	NULL
gene	NULL
.	NULL

The	NULL
data	NULL
therefore	NULL
indicate	NULL
that	NULL
cell-specific	NULL
mechanisms	NULL
,	NULL
perhaps	NULL
involving	NULL
post-transcriptional	NULL
control	NULL
,	NULL
lead	NULL
to	NULL
preferential	NULL
accumulation	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
The	NULL
following	NULL
established	NULL
cell	NULL
lines	NULL
were	NULL
used	NULL
:	NULL
HIT	NULL
M2.2.2-hamster	NULL
pancreatic	NULL
3	NULL
cells	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
;	NULL
3TC1I-mouse	NULL
pancreatic	NULL
3	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
;	NULL
Ltk~	NULL
cells-mouse	NULL
fibroblast	NULL
cell	NULL
;	NULL
BHK	NULL
-hamster	NULL
fibroblast	NULL
cells	NULL
;	NULL
$	NULL
194	NULL
,	NULL
L10AC2	NULL
,	NULL
and	NULL
WEHI	NULL
231	NULL
cells	NULL
B	NULL
lymphoid	NULL
lineage	NULL
:	NULL
$	NULL
194	NULL
cells	NULL
are	NULL
a	NULL
plasmacytoma	NULL
line	NULL
,	NULL
WEHI	NULL
231	NULL
and	NULL
L10AC2	NULL
are	NULL
mature	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

Raji	NULL
is	NULL
a	NULL
human	NULL
lymphoma	NULL
line	NULL
.	NULL

All	NULL
cells	NULL
except	NULL
WEHI	NULL
231	NULL
and	NULL
L10AC2	NULL
were	NULL
grown	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagles	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
penicillin	NULL
(	NULL
200	NULL
I.U./m1	NULL
)	NULL
and	NULL
streptomycin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

For	NULL
WEHI	NULL
231	NULL
cells	NULL
,	NULL
RPMI	NULL
medium	NULL
was	NULL
used	NULL
,	NULL
supplemented	NULL
as	NULL
above	NULL
,	NULL
together	NULL
with	NULL
50	NULL
LM	NULL
$	NULL
-mercaptoethanol	NULL
.	NULL

Generation	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
The	NULL
EZ2A	NULL
gene	NULL
encodes	NULL
two	NULL
closely	NULL
related	NULL
proteins	NULL
,	NULL
products	NULL
of	NULL
alternative	NULL
splicing	NULL
events	NULL
:	NULL
the	NULL
alternate	NULL
cDNAs	NULL
have	NULL
been	NULL
designated	NULL
E47	NULL
and	NULL
E12	NULL
(	NULL
human	NULL
)	NULL
,	NULL
A1	NULL
and	NULL
A7	NULL
(	NULL
mouse	NULL
)	NULL
,	NULL
Pan-1	NULL
and	NULL
Pan-2	NULL
(	NULL
rat	NULL
)	NULL
,	NULL
and	NULL
shPan-1	NULL
and	NULL
shPan-2	NULL
(	NULL
hamster	NULL
)	NULL
(	NULL
6	NULL
,	NULL
11-13	NULL
)	NULL
.	NULL

We	NULL
have	NULL
used	NULL
the	NULL
mouse	NULL
cDNA	NULL
A1	NULL
to	NULL
generate	NULL
polyclonal	NULL
antisera	NULL
;	NULL
fusion	NULL
proteins	NULL
were	NULL
produced	NULL
by	NULL
subcloning	NULL
of	NULL
appropriate	NULL
cDNA	NULL
fragments	NULL
to	NULL
the	NULL
expression	NULL
vector	NULL
pATH	NULL
(	NULL
37	NULL
)	NULL
.	NULL

pATH-A1	NULL
(	NULL
C	NULL
)	NULL
(	NULL
11	NULL
)	NULL
contains	NULL
the	NULL
sequences	NULL
encoding	NULL
the	NULL
C-terminal	NULL
281	NULL
amino	NULL
acids	NULL
of	NULL
A1	NULL
(	NULL
amino	NULL
acids	NULL
369-649	NULL
)	NULL
,	NULL
pATH-A1	NULL
(	NULL
N	NULL
)	NULL
encodes	NULL
336	NULL
amino	NULL
acids	NULL
from	NULL
the	NULL
N-terminus	NULL
of	NULL
A1	NULL
(	NULL
amino	NULL
acids	NULL
50-385	NULL
)	NULL
.	NULL

Bacteria	NULL
containing	NULL
the	NULL
appropriate	NULL
plasmid	NULL
were	NULL
induced	NULL
to	NULL
over-express	NULL
the	NULL
fusion	NULL
protein	NULL
and	NULL
bacterial	NULL
extract	NULL
was	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
sodium	NULL
dodecyl	NULL
sulphate	NULL
gels	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
lightly	NULL
stained	NULL
with	NULL
Coomassie	NULL
brilliant	NULL
blue	NULL
(	NULL
2	NULL
g/l	NULL
in	NULL
H	NULL
,	NULL
O	NULL
)	NULL
.	NULL

The	NULL
band	NULL
corresponding	NULL
to	NULL
fusion	NULL
protein	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
and	NULL
100	NULL
4g	NULL
of	NULL
protein	NULL
was	NULL
injected	NULL
subcutaneously	NULL
into	NULL
rabbits	NULL
as	NULL
a	NULL
suspension	NULL
in	NULL
incomplete	NULL
Freund	NULL
's	NULL
Adjuvant	NULL
.	NULL

After	NULL
three	NULL
injections	NULL
at	NULL
two	NULL
week	NULL
intervals	NULL
,	NULL
serum	NULL
was	NULL
obtained	NULL
and	NULL
tested	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
Proteins	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
were	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
sheets	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Sheets	NULL
were	NULL
soaked	NULL
for	NULL
2	NULL
hours	NULL
in	NULL
blocking	NULL
buffer	NULL
(	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
(	NULL
v	NULL
:	NULL
v	NULL
)	NULL
low	NULL
fat	NULL
milk	NULL
and	NULL
0.05	NULL
%	NULL
Tween-20	NULL
)	NULL
.	NULL

All	NULL
further	NULL
incubation	NULL
steps	NULL
and	NULL
washes	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
above	NULL
buffer	NULL
.	NULL

Sheets	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
two	NULL
hours	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
1/2,000	NULL
dilution	NULL
of	NULL
appropriate	NULL
antibody	NULL
.	NULL

Following	NULL
three	NULL
washes	NULL
in	NULL
blocking	NULL
buffer	NULL
,	NULL
protein	NULL
A-horseradish	NULL
peroxidase	NULL
(	NULL
Amersham	NULL
)	NULL
(	NULL
1/10,000	NULL
dilution	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
incubation	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
an	NULL
additional	NULL
two	NULL
hours	NULL
.	NULL

For	NULL
visualization	NULL
of	NULL
antibody-antigen	NULL
complexes	NULL
,	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
was	NULL
employed	NULL
,	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Immunoprecipitation	NULL
Protein-A-sepharose	NULL
beads	NULL
(	NULL
Sigma	NULL
)	NULL
were	NULL
pre-incubated	NULL
with	NULL
the	NULL
appropriate	NULL
anti-sera	NULL
in	NULL
150	NULL
L1	NULL
PBS	NULL
for	NULL
90	NULL
min	NULL
.	NULL

Following	NULL
three	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
nuclear	NULL
extract	NULL
was	NULL
added	NULL
(	NULL
300	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
two	NULL
hours	NULL
at	NULL
4Â°C	NULL
.	NULL

Subsequently	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
PBS	NULL
and	NULL
then	NULL
sample	NULL
buffer	NULL
(	NULL
38	NULL
)	NULL
was	NULL
added	NULL
.	NULL

Samples	NULL
were	NULL
heated	NULL
at	NULL
100Â°C	NULL
for	NULL
3	NULL
min	NULL
and	NULL
the	NULL
supernatant	NULL
solutions	NULL
were	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Figure	NULL
1	NULL
.	NULL

A	NULL
,	NULL
B	NULL
:	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
100	NULL
ug	NULL
protein	NULL
)	NULL
derived	NULL
from	NULL
8TC1	NULL
,	NULL
HIT	NULL
M2.2.2	NULL
,	NULL
WEHI	NULL
231	NULL
,	NULL
BHK	NULL
,	NULL
and	NULL
LtkÂ®	NULL
cell	NULL
lines	NULL
.	NULL

Extracts	NULL
were	NULL
fractionated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
either	NULL
C-terminus	NULL
(	NULL
Fig	NULL
1	NULL
A	NULL
)	NULL
or	NULL
N-terminus	NULL
(	NULL
Fig	NULL
1	NULL
B	NULL
)	NULL
fragments	NULL
of	NULL
the	NULL
A1	NULL
protein	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
ECL	NULL
protein-A-HRP	NULL
detection	NULL
procedure	NULL
as	NULL
described	NULL
.	NULL

Molecular	NULL
weights	NULL
indicated	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
mobility	NULL
of	NULL
standard	NULL
proteins	NULL
(	NULL
Rainbow	NULL
markers-Amersham	NULL
)	NULL
.	NULL

C	NULL
,	NULL
D	NULL
:	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
200	NULL
ug	NULL
protein	NULL
)	NULL
from	NULL
HIT	NULL
M2.2.2	NULL
,	NULL
Ltk~	NULL
,	NULL
and	NULL
WEHI	NULL
231	NULL
cells	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
fractionated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
either	NULL
C-terminus	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
or	NULL
N-terminus	NULL
(	NULL
Fig	NULL
1D	NULL
)	NULL
fragments	NULL
of	NULL
the	NULL
A1	NULL
protein	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
ECL	NULL
protein-A-HRP	NULL
detection	NULL
procedure	NULL
as	NULL
described	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
is	NULL
indicated	NULL
.	NULL

Preparation	NULL
of	NULL
cell	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

For	NULL
whole	NULL
cell	NULL
lysate	NULL
extracts	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
pelleted	NULL
as	NULL
above	NULL
.	NULL

Subsequently	NULL
,	NULL
100	NULL
gl	NULL
of	NULL
PBS	NULL
and	NULL
100	NULL
ul	NULL
of	NULL
sample	NULL
buffer	NULL
(	NULL
6.25	NULL
mM	NULL
Tris-HCl	NULL
pH	NULL
6.8	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
%	NULL
lithium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
and	NULL
0.005	NULL
%	NULL
bromophenol	NULL
blue	NULL
)	NULL
were	NULL
added	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
sonicated	NULL
for	NULL
2	NULL
min	NULL
in	NULL
a	NULL
sonicator	NULL
bath	NULL
(	NULL
Elma	NULL
transsonic	NULL
310	NULL
)	NULL
,	NULL
and	NULL
then	NULL
heated	NULL
at	NULL
100Â°C	NULL
for	NULL
5	NULL
min	NULL
.	NULL

Protein	NULL
content	NULL
of	NULL
the	NULL
extract	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Lowry	NULL
procedure	NULL
(	NULL
40	NULL
)	NULL
,	NULL
following	NULL
precipitation	NULL
of	NULL
proteins	NULL
by	NULL
addition	NULL
of	NULL
trichloroacetic	NULL
acid	NULL
(	NULL
10	NULL
%	NULL
)	NULL
in	NULL
presence	NULL
of	NULL
sodium	NULL
deoxycholate	NULL
(	NULL
2	NULL
mg/ml	NULL
)	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Transfection	NULL
HIT	NULL
M.2.2.2	NULL
(	NULL
35	NULL
)	NULL
cells	NULL
(	NULL
2x	NULL
106	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
total	NULL
of	NULL
15	NULL
ug	NULL
DNA	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
after	NULL
36	NULL
hours	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
,	NULL
42	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
The	NULL
plasmid	NULL
pBS-ATG-	NULL
#	NULL
267	NULL
contains	NULL
a	NULL
near	NULL
full-length	NULL
Al	NULL
protein	NULL
fused	NULL
in	NULL
frame	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
B	NULL
lactamase	NULL
gene	NULL
to	NULL
generate	NULL
a	NULL
protein	NULL
(	NULL
A267	NULL
)	NULL
of	NULL
almost	NULL
identical	NULL
molecular	NULL
weight	NULL
to	NULL
full	NULL
length	NULL
A1	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
was	NULL
performed	NULL
using	NULL
0.5	NULL
ug	NULL
of	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
T7	NULL
RNA	NULL
polymerase	NULL
.	NULL

Typically	NULL
,	NULL
20	NULL
%	NULL
of	NULL
the	NULL
transcription	NULL
reaction	NULL
was	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
translation	NULL
with	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
(	NULL
Promega	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Lysate	NULL
product	NULL
was	NULL
used	NULL
for	NULL
EMSA	NULL
reactions	NULL
.	NULL

Densitometry	NULL
Autoradiograms	NULL
were	NULL
scanned	NULL
and	NULL
evaluated	NULL
using	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
300A	NULL
Computing	NULL
Densitometer	NULL
.	NULL

antibody	NULL
_	NULL
Â®	NULL
a	NULL
b	NULL
-*	NULL
free	NULL
Figure	NULL
2	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
A1	NULL
proteins	NULL
to	NULL
determine	NULL
specificity	NULL
of	NULL
antisera	NULL
directed	NULL
against	NULL
A1	NULL
proteins	NULL
.	NULL

Clone	NULL
A267	NULL
(	NULL
encoding	NULL
near	NULL
full	NULL
length	NULL
Al	NULL
)	NULL
and	NULL
clone	NULL
A131	NULL
(	NULL
encoding	NULL
the	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
protein	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
reactions	NULL
.	NULL

Translation	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
IEB1	NULL
(	NULL
25	NULL
)	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
added	NULL
IgG	NULL
(	NULL
lanes	NULL
1,5	NULL
)	NULL
,	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IgG	NULL
directed	NULL
against	NULL
trpE	NULL
(	NULL
lanes	NULL
2,6	NULL
)	NULL
,	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
(	NULL
Janes	NULL
3,7	NULL
)	NULL
or	NULL
A1	NULL
(	NULL
N	NULL
)	NULL
(	NULL
lanes	NULL
4,8	NULL
)	NULL
.	NULL

Lanes	NULL
1-4	NULL
contain	NULL
translation	NULL
products	NULL
derived	NULL
from	NULL
clone	NULL
A267	NULL
,	NULL
lanes	NULL
5-8	NULL
contain	NULL
translation	NULL
products	NULL
derived	NULL
from	NULL
clone	NULL
A131	NULL
.	NULL

The	NULL
complexes	NULL
marked	NULL
'	NULL
a	NULL
'	NULL
result	NULL
from	NULL
the	NULL
A267-derived	NULL
protein	NULL
.	NULL

The	NULL
complexes	NULL
marked	NULL
'	NULL
b	NULL
'	NULL
result	NULL
from	NULL
the	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
protein	NULL
.	NULL

The	NULL
complex	NULL
migrating	NULL
slightly	NULL
faster	NULL
than	NULL
'	NULL
b	NULL
'	NULL
corresponds	NULL
to	NULL
a	NULL
non-specific	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
1603	NULL
RESULTS	NULL
To	NULL
determine	NULL
whether	NULL
E2A	NULL
proteins	NULL
,	NULL
like	NULL
E2A	NULL
transcripts	NULL
,	NULL
are	NULL
present	NULL
at	NULL
comparable	NULL
concentrations	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
we	NULL
performed	NULL
immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
using	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
(	NULL
serum	NULL
raised	NULL
against	NULL
the	NULL
carboxy	NULL
terminal	NULL
part	NULL
of	NULL
A1	NULL
(	NULL
27	NULL
)	NULL
)	NULL
.	NULL

A	NULL
73	NULL
kDa	NULL
protein	NULL
was	NULL
efficiently	NULL
identified	NULL
in	NULL
WEHI	NULL
231	NULL
nuclear	NULL
extract	NULL
;	NULL
this	NULL
protein	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
extracts	NULL
from	NULL
fibroblasts	NULL
or	NULL
3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
represents	NULL
an	NULL
EZ2A	NULL
gene	NULL
product	NULL
,	NULL
and	NULL
to	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
recognition	NULL
is	NULL
towards	NULL
an	NULL
HLH	NULL
structural	NULL
determinant	NULL
,	NULL
we	NULL
raised	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
an	NULL
amino	NULL
terminal	NULL
segment	NULL
of	NULL
Al	NULL
(	NULL
see	NULL
Methods	NULL
)	NULL
,	NULL
which	NULL
we	NULL
designate	NULL
A1	NULL
(	NULL
N	NULL
)	NULL
.	NULL

The	NULL
serum	NULL
directed	NULL
against	NULL
A1	NULL
(	NULL
N	NULL
)	NULL
detected	NULL
a	NULL
protein	NULL
of	NULL
identical	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
73	NULL
kDa	NULL
)	NULL
in	NULL
extracts	NULL
from	NULL
WEHI	NULL
231	NULL
cells	NULL
but	NULL
not	NULL
fibroblasts	NULL
or	NULL
3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

The	NULL
reactivity	NULL
to	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
was	NULL
not	NULL
observed	NULL
using	NULL
the	NULL
corresponding	NULL
preimmune	NULL
sera	NULL
or	NULL
anti-trpE	NULL
antiserum	NULL
(	NULL
data	NULL
not	NULL
shown-see	NULL
also	NULL
Fig	NULL
5	NULL
A	NULL
)	NULL
.	NULL

The	NULL
anti-A1	NULL
(	NULL
N	NULL
)	NULL
antiserum	NULL
also	NULL
efficiently	NULL
recognized	NULL
LEF1/BCFI1	NULL
binding	NULL
activity	NULL
upon	NULL
EMSA	NULL
analysis	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
above	NULL
analyses	NULL
were	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
,	NULL
they	NULL
could	NULL
conceivably	NULL
reflect	NULL
differences	NULL
in	NULL
subcellular	NULL
localization	NULL
of	NULL
the	NULL
EZ2A	NULL
proteins	NULL
among	NULL
the	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

We	NULL
therefore	NULL
performed	NULL
immunoblot	NULL
analysis	NULL
using	NULL
extracts	NULL
of	NULL
total	NULL
cell	NULL
lysates	NULL
from	NULL
fibroblasts	NULL
,	NULL
3	NULL
cells	NULL
and	NULL
B	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
obtained	NULL
with	NULL
both	NULL
anti-sera	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
C	NULL
,	NULL
D	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
is	NULL
present	NULL
at	NULL
substantially	NULL
higher	NULL
levels	NULL
in	NULL
lymphoid	NULL
cells	NULL
compared	NULL
to	NULL
fibroblast	NULL
and	NULL
(	NULL
3	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
differential	NULL
signals	NULL
observed	NULL
using	NULL
nuclear	NULL
extracts	NULL
are	NULL
not	NULL
attributable	NULL
to	NULL
differential	NULL
subcellular	NULL
localization	NULL
.	NULL

$	NULL
194	NULL
WEHI	NULL
LIOA	NULL
RAJI	NULL
BHK	NULL
_	NULL
LTK	NULL
73kDa	NULL
-	NULL
Â»	NULL
_	NULL
.	NULL

@	NULL
i	NULL
1a	NULL
Â«	NULL
4	NULL
4.40	NULL
a	NULL
444m	NULL
%	NULL
*	NULL
I	NULL
2	NULL
3	NULL
4	NULL
i	NULL
6	NULL
DENSITOMETRIC	NULL
ANALYSIS	NULL
ARBITRARY	NULL
UNITS	NULL
Figure	NULL
3	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
100	NULL
ug	NULL
protein	NULL
)	NULL
derived	NULL
from	NULL
$	NULL
194	NULL
,	NULL
WEHI	NULL
231	NULL
,	NULL
L10AC2	NULL
,	NULL
Raji	NULL
,	NULL
Ltk~	NULL
and	NULL
BHK	NULL
cell	NULL
lines	NULL
.	NULL

Top	NULL
panel-extracts	NULL
were	NULL
fractionated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
.	NULL

Proteins	NULL
were	NULL
detected	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
C-terminus	NULL
of	NULL
the	NULL
A1	NULL
protein	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
developed	NULL
using	NULL
the	NULL
ECL	NULL
protein-A-HRP	NULL
detection	NULL
procedure	NULL
as	NULL
described	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
is	NULL
indicated	NULL
.	NULL

Bottom	NULL
panel-quantitative	NULL
densitometric	NULL
analysis	NULL
of	NULL
above	NULL
immunoblot	NULL
.	NULL

1604	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
To	NULL
confirm	NULL
that	NULL
the	NULL
two	NULL
antisera	NULL
recognize	NULL
distinct	NULL
epitopes	NULL
on	NULL
E2A	NULL
proteins	NULL
,	NULL
we	NULL
tested	NULL
their	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
E2A	NULL
proteins	NULL
using	NULL
EMSA	NULL
analysis	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
recognizes	NULL
both	NULL
in	NULL
vitro	NULL
translated	NULL
A267	NULL
(	NULL
encoded	NULL
by	NULL
a	NULL
near-full	NULL
length	NULL
A1	NULL
cDNA	NULL
(	NULL
pBS-ATG-	NULL
#	NULL
267	NULL
)	NULL
spanning	NULL
both	NULL
A1	NULL
(	NULL
N	NULL
)	NULL
and	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
proteins	NULL
)	NULL
and	NULL
in	NULL
vitro	NULL
translated	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
protein	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lanes	NULL
3,7	NULL
)	NULL
.	NULL

Anti-A1	NULL
(	NULL
N	NULL
)	NULL
antisera	NULL
recognized	NULL
efficiently	NULL
the	NULL
A267	NULL
protein	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
showed	NULL
essentially	NULL
no	NULL
recognition	NULL
of	NULL
the	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
protein	NULL
(	NULL
Fig	NULL
2	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
epitopes	NULL
recognized	NULL
by	NULL
A1	NULL
(	NULL
N	NULL
)	NULL
antisera	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
on	NULL
the	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
protein	NULL
;	NULL
the	NULL
efficient	NULL
cell-specific	NULL
recognition	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
by	NULL
both	NULL
antisera	NULL
is	NULL
a	NULL
strong	NULL
indication	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
is	NULL
an	NULL
E2A	NULL
gene	NULL
product	NULL
.	NULL

We	NULL
further	NULL
analyzed	NULL
whether	NULL
other	NULL
lymphoid	NULL
cells	NULL
exhibit	NULL
increased	NULL
levels	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
using	NULL
immunoblot	NULL
analysis	NULL
probed	NULL
with	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
$	NULL
194	NULL
,	NULL
L10AC2	NULL
and	NULL
Raji	NULL
cells	NULL
showed	NULL
increased	NULL
levels	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
compared	NULL
to	NULL
fibroblast	NULL
cell	NULL
extracts	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
increased	NULL
levels	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
is	NULL
a	NULL
more	NULL
general	NULL
characteristic	NULL
of	NULL
B-lymphoid	NULL
cells	NULL
;	NULL
moreover	NULL
the	NULL
ability	NULL
to	NULL
detect	NULL
the	NULL
E2A	NULL
protein	NULL
product	NULL
in	NULL
these	NULL
cells	NULL
extract	NULL
correlates	NULL
with	NULL
the	NULL
LEF1/BCFI	NULL
binding	NULL
activity	NULL
detected	NULL
using	NULL
EMSA	NULL
analysis	NULL
(	NULL
27	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
detection	NULL
system	NULL
employed	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
is	NULL
based	NULL
on	NULL
enzymatic	NULL
activity	NULL
(	NULL
horseradish	NULL
peroxidase	NULL
conjugated	NULL
to	NULL
protein-A	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
purified	NULL
glutathione	NULL
S-transferase	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
HLH	NULL
domain	NULL
of	NULL
E2A	NULL
protein	NULL
,	NULL
a	NULL
linear	NULL
response	NULL
was	NULL
obtained	NULL
in	NULL
the	NULL
range	NULL
of	NULL
0-50	NULL
ug	NULL
of	NULL
purified	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
quantitatively	NULL
compare	NULL
the	NULL
expression	NULL
in	NULL
B	NULL
lymphoid	NULL
cells	NULL
to	NULL
that	NULL
in	NULL
fibroblasts	NULL
,	NULL
we	NULL
performed	NULL
immunoblot	NULL
analysis	NULL
using	NULL
serial	NULL
dilutions	NULL
of	NULL
WEHI	NULL
Figure	NULL
4	NULL
.	NULL

A	NULL
:	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
WEHI-231	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
indicated	NULL
amounts	NULL
of	NULL
Ltk~	NULL
and	NULL
WEHI-231	NULL
nuclear	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
using	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
.	NULL

B	NULL
:	NULL
The	NULL
autoradiogram	NULL
was	NULL
analyzed	NULL
using	NULL
quantitative	NULL
densitometric	NULL
analysis	NULL
.	NULL

Left	NULL
panel	NULL
measurement	NULL
of	NULL
73	NULL
kDa	NULL
band	NULL
from	NULL
each	NULL
lane	NULL
of	NULL
Figure	NULL
4A	NULL
.	NULL

Right	NULL
panel-absorbance	NULL
measurement	NULL
of	NULL
73	NULL
kDa	NULL
band	NULL
from	NULL
serial	NULL
dilutions	NULL
of	NULL
WEHI	NULL
231	NULL
extract	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
231	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
analysis	NULL
,	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
is	NULL
at	NULL
least	NULL
15-fold	NULL
more	NULL
abundant	NULL
in	NULL
WEHI	NULL
231	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
and	NULL
L10AC2	NULL
extracts	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
as	NULL
compared	NULL
to	NULL
fibroblast	NULL
(	NULL
Ltk~	NULL
)	NULL
extracts	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
,	NULL
LEF1/BCF1	NULL
and	NULL
E2A	NULL
gene	NULL
products	NULL
was	NULL
further	NULL
examined	NULL
using	NULL
an	NULL
immunoprecipitation	NULL
procedure	NULL
.	NULL

Anti-A1	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
but	NULL
not	NULL
pre-immune	NULL
serum	NULL
was	NULL
able	NULL
to	NULL
efficiently	NULL
immunoprecipitate	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
(	NULL
Fig	NULL
5	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
supernatant	NULL
solution	NULL
remaining	NULL
following	NULL
immunoprecipitation	NULL
was	NULL
tested	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
LEF1/BCFI1	NULL
binding	NULL
activity	NULL
using	NULL
EMSA	NULL
(	NULL
Fig	NULL
5	NULL
B	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
untreated	NULL
nuclear	NULL
extract	NULL
(	NULL
lane	NULL
marked	NULL
'-	NULL
'	NULL
)	NULL
and	NULL
the	NULL
extract	NULL
treated	NULL
with	NULL
pre-immune	NULL
serum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
contained	NULL
LEF1I/BCFIL	NULL
activity	NULL
;	NULL
the	NULL
extract	NULL
treated	NULL
with	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
was	NULL
completely	NULL
depleted	NULL
of	NULL
LEFI/BCF1	NULL
activity	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
immunoprecipitation	NULL
by	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
correlates	NULL
with	NULL
depletion	NULL
of	NULL
LEF1/BCFI	NULL
binding	NULL
activity	NULL
from	NULL
the	NULL
extracts	NULL
.	NULL

The	NULL
observed	NULL
size	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
corresponds	NULL
fairly	NULL
well	NULL
with	NULL
the	NULL
calculated	NULL
molecular	NULL
weight	NULL
of	NULL
E2A	NULL
protein	NULL
(	NULL
67-68	NULL
kDa	NULL
)	NULL
based	NULL
on	NULL
cDNA	NULL
sequences	NULL
(	NULL
13	NULL
,	NULL
43	NULL
)	NULL
and	NULL
with	NULL
the	NULL
mobility	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
EZ2A	NULL
proteins	NULL
on	NULL
SDS	NULL
and	NULL
EMSA	NULL
gel	NULL
electrophoresis	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
more	NULL
directly	NULL
the	NULL
size	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
lymphoid	NULL
cell	NULL
protein	NULL
with	NULL
the	NULL
protein	NULL
product	NULL
of	NULL
the	NULL
full	NULL
length	NULL
cloned	NULL
cDNA	NULL
of	NULL
A1	NULL
and	NULL
A7	NULL
,	NULL
we	NULL
expressed	NULL
these	NULL
cDNAs	NULL
in	NULL
vivo	NULL
.	NULL

Expression	NULL
plasmids	NULL
containing	NULL
cDNAs	NULL
encoding	NULL
full	NULL
length	NULL
A1	NULL
and	NULL
A7	NULL
under	NULL
the	NULL
control	NULL
of	NULL
a	NULL
viral	NULL
promoter	NULL
(	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
HIT	NULL
cells	NULL
,	NULL
a	NULL
pancreatic	NULL
3	NULL
cell	NULL
line	NULL
chosen	NULL
for	NULL
this	NULL
experiment	NULL
because	NULL
of	NULL
its	NULL
relatively	NULL
high	NULL
transfection	NULL
efficiency	NULL
and	NULL
low	NULL
basal	NULL
levels	NULL
of	NULL
endogenous	NULL
73	NULL
kDa	NULL
protein	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
antibodies	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
full	NULL
length	NULL
cDNA	NULL
showed	NULL
a	NULL
band	NULL
absent	NULL
in	NULL
non-transfected	NULL
control	NULL
cells	NULL
and	NULL
that	NULL
co-migrated	NULL
with	NULL
the	NULL
73	NULL
kDa	NULL
lymphoid	NULL
cell	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
when	NULL
the	NULL
extracts	NULL
from	NULL
transfected	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
with	NULL
an	NULL
E	NULL
box	NULL
probe	NULL
(	NULL
xE4	NULL
,	NULL
which	NULL
is	NULL
efficiently	NULL
recognized	NULL
by	NULL
LEF1/BCFI1	NULL
(	NULL
27	NULL
)	NULL
)	NULL
,	NULL
a	NULL
protein-DNA	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
identical	NULL
migration	NULL
compared	NULL
to	NULL
LEF1I/BCFI	NULL
Â«	NULL
<	NULL
9	NULL
owe	NULL
~~	NULL
Figure	NULL
5	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
WEHI	NULL
231	NULL
cells	NULL
using	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
antiserum	NULL
.	NULL

Immunoprecipitates	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
using	NULL
pre-immune	NULL
serum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
anti-A1	NULL
(	NULL
C	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
and	NULL
immunoblot	NULL
analysis	NULL
using	NULL
anti	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
antisera	NULL
.	NULL

Molecular	NULL
weights	NULL
indicated	NULL
are	NULL
derived	NULL
from	NULL
the	NULL
mobility	NULL
of	NULL
standard	NULL
proteins	NULL
(	NULL
Rainbow	NULL
markers-Amersham	NULL
)	NULL
.	NULL

The	NULL
prominent	NULL
band	NULL
at	NULL
50	NULL
kDa	NULL
corresponds	NULL
to	NULL
IgG	NULL
heavy	NULL
chain	NULL
present	NULL
in	NULL
the	NULL
immunoprecipitates	NULL
and	NULL
recognized	NULL
by	NULL
protein	NULL
A-HRP	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
EMSA	NULL
analysis	NULL
of	NULL
the	NULL
supernatant	NULL
solution	NULL
remaining	NULL
following	NULL
treatment	NULL
with	NULL
antiserum	NULL
.	NULL

Nuclear	NULL
extracts	NULL
following	NULL
treatment	NULL
with	NULL
no	NULL
antiserum	NULL
(	NULL
lane	NULL
marked	NULL
'-	NULL
'	NULL
)	NULL
,	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
anti	NULL
A1	NULL
(	NULL
C	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
with	NULL
the	NULL
E	NULL
box	NULL
probe	NULL
IEBI1	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
LEFI/BCF1	NULL
is	NULL
indicated	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
compare	NULL
lane	NULL
2	NULL
and	NULL
lane	NULL
3	NULL
,	NULL
4	NULL
)	NULL
and	NULL
also	NULL
identical	NULL
to	NULL
the	NULL
complex	NULL
obtained	NULL
with	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
corresponding	NULL
in	NULL
size	NULL
to	NULL
the	NULL
full	NULL
length	NULL
cDNA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
identified	NULL
by	NULL
immunoblot	NULL
using	NULL
anti-E2A	NULL
antibodies	NULL
represents	NULL
the	NULL
cellular	NULL
E2A	NULL
protein	NULL
.	NULL

DISCUSSION	NULL
Cell-specific	NULL
expression	NULL
of	NULL
genes	NULL
derived	NULL
from	NULL
diverse	NULL
cell	NULL
lineages	NULL
requires	NULL
the	NULL
cis	NULL
elements	NULL
known	NULL
as	NULL
E	NULL
boxes	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
these	NULL
sequences	NULL
appears	NULL
to	NULL
be	NULL
their	NULL
ability	NULL
to	NULL
be	NULL
recognized	NULL
by	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
HLH	NULL
family	NULL
.	NULL

This	NULL
rapidly	NULL
growing	NULL
family	NULL
of	NULL
proteins	NULL
has	NULL
been	NULL
classified	NULL
into	NULL
3	NULL
groups	NULL
designated	NULL
basic-HLH	NULL
domain	NULL
(	NULL
bHLH	NULL
)	NULL
and	NULL
bHLH-zip	NULL
(	NULL
basic	NULL
HLH-leucine	NULL
zipper	NULL
)	NULL
and	NULL
dnHLH	NULL
(	NULL
dominant	NULL
negative	NULL
)	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Within	NULL
the	NULL
bHLH	NULL
proteins	NULL
,	NULL
a	NULL
further	NULL
sub-classification	NULL
has	NULL
been	NULL
made	NULL
according	NULL
to	NULL
tissue	NULL
distribution	NULL
:	NULL
cell-specifically	NULL
expressed	NULL
bHLH	NULL
proteins	NULL
such	NULL
as	NULL
MyoD	NULL
and	NULL
achaete	NULL
scute	NULL
appear	NULL
to	NULL
homodimerize	NULL
inefficiently	NULL
,	NULL
although	NULL
they	NULL
can	NULL
heterodimerize	NULL
with	NULL
'constitutively	NULL
'	NULL
expressed	NULL
bHLH	NULL
proteins	NULL
such	NULL
as	NULL
E2A	NULL
to	NULL
produce	NULL
an	NULL
efficient	NULL
DNA	NULL
binding	NULL
complex	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
from	NULL
the	NULL
bHLH	NULL
family	NULL
can	NULL
also	NULL
heterodimerize	NULL
with	NULL
dnHLH	NULL
to	NULL
produce	NULL
a	NULL
protein	NULL
complex	NULL
incapable	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

Enhancers	NULL
of	NULL
immunoglobulin	NULL
genes	NULL
contain	NULL
multiple	NULL
E	NULL
boxes	NULL
whose	NULL
importance	NULL
was	NULL
originally	NULL
recognized	NULL
by	NULL
in	NULL
vivo	NULL
footprint	NULL
experiments	NULL
:	NULL
the	NULL
E	NULL
boxes	NULL
showed	NULL
lymphoid	NULL
selective	NULL
footprinting	NULL
(	NULL
1	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Mutagenesis	NULL
experiments	NULL
revealed	NULL
that	NULL
the	NULL
E	NULL
boxes	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
in	NULL
vivo	NULL
activity	NULL
of	NULL
immunoglobulin	NULL
enhancers	NULL
(	NULL
2	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
an	NULL
E	NULL
box	NULL
binding	NULL
nuclear	NULL
complex	NULL
(	NULL
LEF1/BCF1	NULL
)	NULL
was	NULL
identified	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
efficiently	NULL
recognized	NULL
by	NULL
antibodies	NULL
directed	NULL
against	NULL
E2A	NULL
proteins	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
EZ2A	NULL
proteins	NULL
in	NULL
the	NULL
complex	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
preferential	NULL
recognition	NULL
of	NULL
this	NULL
complex	NULL
as	NULL
compared	NULL
to	NULL
heterodimeric	NULL
complexes	NULL
between	NULL
E2A	NULL
proteins	NULL
and	NULL
MyoD	NULL
,	NULL
and	NULL
on	NULL
the	NULL
co-migration	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
expressed	NULL
E2A	NULL
gene	NULL
products	NULL
,	NULL
it	NULL
has	NULL
been	NULL
A	NULL
B	NULL
WESTERN	NULL
USING	NULL
ANTI-A1	NULL
GEL	NULL
MOBILITY	NULL
SHIFT	NULL
TRANSFECTED	NULL
â	NULL
*	NULL
A7	NULL
A1	NULL
-	NULL
-	NULL
A7	NULL
A1	NULL
EXTRACT	NULL
HIT	NULL
WEHIL	NULL
HIT	NULL
-	NULL
HIT	NULL
HIT	NULL
WEHI	NULL
-	NULL
HIT	NULL
-	NULL
HIT	NULL
A1	NULL
LEF1	NULL
--	NULL
Â»	NULL
trig	NULL
wor-	NULL
waa	NULL
IEF1	NULL
-	NULL
--	NULL
a	NULL
Â»	NULL
-	NULL
Am	NULL
te	NULL
#	NULL
*	NULL
*	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
ewam	NULL
Â«	NULL
--	NULL
Â»	NULL
Grie	NULL
to	NULL
ap	NULL
came	NULL
vo	NULL
Ap	NULL
-at	NULL
73	NULL
kDa	NULL
--	NULL
i	NULL
Â»	NULL
Figure	NULL
6	NULL
.	NULL

Analysis	NULL
of	NULL
E2A	NULL
protein	NULL
products	NULL
expressed	NULL
in	NULL
transfected	NULL
insulin	NULL
producing	NULL
cells	NULL
.	NULL

HIT	NULL
M2.2.2	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
plasmid	NULL
expressing	NULL
the	NULL
complete	NULL
coding	NULL
sequence	NULL
of	NULL
A7	NULL
or	NULL
A1	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Rous	NULL
Sarcoma	NULL
Virus	NULL
(	NULL
RSV	NULL
)	NULL
enhancer	NULL
promoter	NULL
.	NULL

36h	NULL
following	NULL
the	NULL
transfection	NULL
,	NULL
nuclear	NULL
extract	NULL
was	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
A1	NULL
(	NULL
Fig	NULL
6	NULL
A	NULL
)	NULL
and	NULL
EMSA	NULL
analysis	NULL
using	NULL
the	NULL
E	NULL
box	NULL
sequence	NULL
#	NULL
E4	NULL
(	NULL
Fig	NULL
6	NULL
B	NULL
)	NULL
.	NULL

In	NULL
both	NULL
panels	NULL
,	NULL
the	NULL
lanes	NULL
contain	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
following	NULL
cells	NULL
:	NULL
HIT	NULL
M2.2.2	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
WEHI	NULL
231	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
HIT	NULL
M2.2.2	NULL
transfected	NULL
with	NULL
full	NULL
length	NULL
A7	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
HIT	NULL
M2.2.2	NULL
transfected	NULL
with	NULL
full	NULL
length	NULL
Al	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

HIT	NULL
and	NULL
WEHI	NULL
231	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
as	NULL
size	NULL
references	NULL
for	NULL
the	NULL
E2A	NULL
protein	NULL
product	NULL
(	NULL
73	NULL
kDa	NULL
)	NULL
,	NULL
and	NULL
the	NULL
IEF1	NULL
and	NULL
LEFI/BCF1	NULL
binding	NULL
activities	NULL
.	NULL

Panel	NULL
B	NULL
lane	NULL
5	NULL
contains	NULL
the	NULL
in	NULL
vitro	NULL
translation	NULL
product	NULL
generated	NULL
from	NULL
full	NULL
length	NULL
A1	NULL
cDNA	NULL
of	NULL
the	NULL
EZA	NULL
gene	NULL
(	NULL
A267	NULL
protein	NULL
)	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
1605	NULL
suggested	NULL
that	NULL
LEF1/BCF1	NULL
corresponds	NULL
to	NULL
a	NULL
homodimer	NULL
of	NULL
E2A	NULL
proteins	NULL
(	NULL
31	NULL
)	NULL
.	NULL

This	NULL
conclusion	NULL
however	NULL
can	NULL
not	NULL
explain	NULL
the	NULL
apparent	NULL
absence	NULL
of	NULL
LEF1/BCF1	NULL
in	NULL
extracts	NULL
of	NULL
non-lymphoid	NULL
cells	NULL
given	NULL
the	NULL
presence	NULL
of	NULL
E2A	NULL
RNA	NULL
and	NULL
protein	NULL
in	NULL
such	NULL
cells	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
E2A	NULL
gene	NULL
products	NULL
recognize	NULL
the	NULL
cell-specific	NULL
complexes	NULL
IEF1	NULL
(	NULL
12	NULL
,	NULL
27-29	NULL
)	NULL
and	NULL
LEFI/BCFI	NULL
(	NULL
27	NULL
,	NULL
31-33	NULL
)	NULL
suggesting	NULL
that	NULL
these	NULL
complexes	NULL
contain	NULL
E2A	NULL
gene	NULL
products	NULL
.	NULL

We	NULL
used	NULL
two	NULL
independently	NULL
derived	NULL
antisera	NULL
,	NULL
one	NULL
directed	NULL
towards	NULL
the	NULL
N-terminal	NULL
portion	NULL
of	NULL
A1	NULL
and	NULL
the	NULL
other	NULL
to	NULL
the	NULL
C-terminal	NULL
portion	NULL
of	NULL
A1	NULL
,	NULL
to	NULL
determine	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
using	NULL
immunoblot	NULL
analysis	NULL
.	NULL

With	NULL
both	NULL
antibodies	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
prominent	NULL
protein	NULL
of	NULL
73	NULL
kDa	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
B	NULL
lymphoid	NULL
cells	NULL
;	NULL
the	NULL
protein	NULL
was	NULL
barely	NULL
detectable	NULL
(	NULL
at	NULL
least	NULL
15-fold	NULL
lower	NULL
levels	NULL
)	NULL
in	NULL
extracts	NULL
from	NULL
fibroblast	NULL
or	NULL
{	NULL
3	NULL
cells	NULL
.	NULL

This	NULL
result	NULL
was	NULL
also	NULL
obtained	NULL
using	NULL
whole	NULL
cell	NULL
lysates	NULL
.	NULL

The	NULL
lymphoid	NULL
cell	NULL
preference	NULL
and	NULL
the	NULL
recognition	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
by	NULL
2	NULL
distinct	NULL
anti-A1	NULL
antisera	NULL
indicates	NULL
strongly	NULL
that	NULL
the	NULL
protein	NULL
corresponds	NULL
to	NULL
a	NULL
product	NULL
of	NULL
the	NULL
EZ2A	NULL
gene	NULL
and	NULL
is	NULL
a	NULL
component	NULL
of	NULL
LEFI/BCF1	NULL
.	NULL

The	NULL
Jurkat	NULL
cell	NULL
line	NULL
(	NULL
human	NULL
T	NULL
lymphoid	NULL
)	NULL
also	NULL
shows	NULL
substantial	NULL
levels	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Several	NULL
additional	NULL
lines	NULL
of	NULL
evidence	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
indeed	NULL
corresponds	NULL
to	NULL
the	NULL
cellular	NULL
E2A	NULL
protein	NULL
product	NULL
:	NULL
1	NULL
.	NULL

Transfection	NULL
experiments	NULL
,	NULL
in	NULL
which	NULL
full	NULL
length	NULL
E2A	NULL
gene	NULL
products	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
cultured	NULL
3	NULL
cells	NULL
:	NULL
upon	NULL
transfection	NULL
,	NULL
extracts	NULL
from	NULL
such	NULL
cells	NULL
showed	NULL
proteins	NULL
which	NULL
co-migrated	NULL
with	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
on	NULL
immunoblot	NULL
analysis	NULL
following	NULL
SDS-PAGE	NULL
and	NULL
generated	NULL
protein-DNA	NULL
complexes	NULL
in	NULL
vitro	NULL
which	NULL
co-migrated	NULL
with	NULL
LEF1/BCF1	NULL
on	NULL
EMSA	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

2	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
using	NULL
anti-E2A	NULL
protein	NULL
antibodies	NULL
,	NULL
of	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
from	NULL
lymphoid	NULL
extracts	NULL
correlates	NULL
with	NULL
the	NULL
loss	NULL
of	NULL
LEF1I/BCF1	NULL
binding	NULL
activity	NULL
of	NULL
this	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

3	NULL
.	NULL

In	NULL
a	NULL
parallel	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
screened	NULL
a	NULL
Agt11	NULL
expression	NULL
library	NULL
from	NULL
a	NULL
late	NULL
pre-B	NULL
lymphoid	NULL
cell	NULL
line	NULL
70Z	NULL
(	NULL
which	NULL
contain	NULL
both	NULL
LEF1/BCF1	NULL
and	NULL
the	NULL
73	NULL
kDa	NULL
protein-data	NULL
not	NULL
shown	NULL
)	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
C-terminus	NULL
of	NULL
A1	NULL
.	NULL

Of	NULL
7	NULL
clones	NULL
identified	NULL
,	NULL
sequencing	NULL
analysis	NULL
has	NULL
shown	NULL
that	NULL
all	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
EZ2A	NULL
gene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
this	NULL
underscores	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
anti-A	NULL
1	NULL
antibodies	NULL
towards	NULL
the	NULL
E2A	NULL
gene	NULL
product	NULL
,	NULL
and	NULL
argues	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
73	NULL
kDa	NULL
protein	NULL
may	NULL
be	NULL
a	NULL
product	NULL
of	NULL
a	NULL
related	NULL
gene	NULL
,	NULL
eg	NULL
.	NULL

ITF2	NULL
(	NULL
9	NULL
)	NULL
or	NULL
HEB	NULL
(	NULL
46	NULL
)	NULL
,	NULL
recognized	NULL
by	NULL
anti-Al	NULL
antibodies	NULL
because	NULL
of	NULL
immunological	NULL
cross-reactivity	NULL
.	NULL

In	NULL
this	NULL
work	NULL
,	NULL
we	NULL
present	NULL
data	NULL
which	NULL
can	NULL
explain	NULL
the	NULL
fact	NULL
that	NULL
LEFI/BCF1	NULL
binding	NULL
activity	NULL
is	NULL
restricted	NULL
to	NULL
lymphoid	NULL
cells	NULL
:	NULL
lymphoid	NULL
cells	NULL
have	NULL
dramatically	NULL
elevated	NULL
levels	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
as	NULL
compared	NULL
with	NULL
other	NULL
cells	NULL
.	NULL

This	NULL
can	NULL
account	NULL
for	NULL
the	NULL
ready	NULL
detection	NULL
of	NULL
homodimeric	NULL
E2A	NULL
complexes	NULL
(	NULL
LEF1/BCF1	NULL
)	NULL
,	NULL
capable	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
,	NULL
E2A	NULL
gene	NULL
products	NULL
are	NULL
present	NULL
at	NULL
substantially	NULL
lower	NULL
levels	NULL
(	NULL
at	NULL
least	NULL
15-fold	NULL
less	NULL
)	NULL
and	NULL
presumably	NULL
insufficient	NULL
homodimer	NULL
can	NULL
form	NULL
to	NULL
produce	NULL
detectable	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
endocrine	NULL
cells	NULL
or	NULL
muscle	NULL
cells	NULL
,	NULL
where	NULL
E	NULL
box	NULL
binding	NULL
activity	NULL
is	NULL
detected	NULL
,	NULL
the	NULL
binding	NULL
complexes	NULL
appear	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
heterodimers	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
together	NULL
with	NULL
cell	NULL
specific	NULL
HLH	NULL
proteins	NULL
such	NULL
as	NULL
MyoD	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
detect	NULL
such	NULL
DNA	NULL
binding	NULL
complexes	NULL
,	NULL
despite	NULL
the	NULL
apparently	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
EZ2A	NULL
proteins	NULL
,	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
known	NULL
dimerization	NULL
and	NULL
DNA-binding	NULL
properties	NULL
of	NULL
E2A	NULL
proteins	NULL
:	NULL
for	NULL
example	NULL
,	NULL
E47	NULL
forms	NULL
heterodimers	NULL
with	NULL
MyoD	NULL
much	NULL
more	NULL
readily	NULL
than	NULL
homodimers	NULL
with	NULL
itself	NULL
;	NULL
E12	NULL
binds	NULL
DNA	NULL
very	NULL
poorly	NULL
as	NULL
a	NULL
homodimer	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
above	NULL
1606	NULL
Nucleic	NULL
Acids	NULL
Research	NULL
,	NULL
1993	NULL
,	NULL
Vol	NULL
.	NULL

21	NULL
,	NULL
No	NULL
.	NULL

7	NULL
explanation	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
ability	NULL
to	NULL
generate	NULL
an	NULL
-like	NULL
binding	NULL
activity	NULL
in	NULL
3	NULL
cells	NULL
upon	NULL
transfection	NULL
with	NULL
an	NULL
E2A	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
precise	NULL
role	NULL
of	NULL
LEF1I/BCF1	NULL
in	NULL
control	NULL
of	NULL
lymphoid	NULL
cell	NULL
gene	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Its	NULL
preferential	NULL
appearance	NULL
in	NULL
cells	NULL
where	NULL
immunoglobulin	NULL
enhancers	NULL
are	NULL
active	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
,	NULL
its	NULL
ability	NULL
in	NULL
vitro	NULL
to	NULL
bind	NULL
several	NULL
of	NULL
the	NULL
key	NULL
E	NULL
boxes	NULL
of	NULL
immunoglobulin	NULL
enhancers	NULL
(	NULL
27	NULL
,	NULL
31	NULL
)	NULL
,	NULL
together	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
E2A	NULL
proteins	NULL
to	NULL
trans-activate	NULL
reporter	NULL
plasmids	NULL
containing	NULL
multiple	NULL
E	NULL
box	NULL
sequences	NULL
(	NULL
9	NULL
)	NULL
and	NULL
activate	NULL
germ	NULL
line	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
transcription	NULL
(	NULL
48	NULL
)	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
as	NULL
a	NULL
lymphoid	NULL
cell-specific	NULL
transcriptional	NULL
activator	NULL
of	NULL
immunoglobulin	NULL
enhancers	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
cell-specific	NULL
factor	NULL
appears	NULL
to	NULL
be	NULL
composed	NULL
of	NULL
proteins	NULL
which	NULL
had	NULL
hitherto	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
'constitutive	NULL
'	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
indicates	NULL
that	NULL
there	NULL
are	NULL
substantially	NULL
higher	NULL
concentrations	NULL
of	NULL
E2A	NULL
proteins	NULL
in	NULL
cells	NULL
of	NULL
B	NULL
lymphoid	NULL
lineage	NULL
than	NULL
in	NULL
fibroblasts	NULL
or	NULL
3	NULL
cells	NULL
.	NULL

It	NULL
appears	NULL
therefore	NULL
that	NULL
distinct	NULL
cell	NULL
lineages	NULL
use	NULL
different	NULL
strategies	NULL
to	NULL
generate	NULL
the	NULL
characteristic	NULL
HLH	NULL
transcription	NULL
complexes	NULL
that	NULL
are	NULL
necessary	NULL
for	NULL
generating	NULL
unique	NULL
patterns	NULL
of	NULL
cell-specific	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
pancreatic	NULL
3	NULL
cells	NULL
and	NULL
muscle	NULL
cells	NULL
,	NULL
heterodimeric	NULL
complexes	NULL
are	NULL
formed	NULL
between	NULL
a	NULL
cell-specific	NULL
HLH	NULL
protein	NULL
(	NULL
eg	NULL
IESF1	NULL
,	NULL
MyoD	NULL
)	NULL
and	NULL
E2A	NULL
proteins	NULL
(	NULL
present	NULL
at	NULL
low	NULL
concentrations	NULL
in	NULL
non-lymphoid	NULL
cells	NULL
)	NULL
.	NULL

In	NULL
B	NULL
lymphoid	NULL
cells	NULL
,	NULL
the	NULL
accumulation	NULL
of	NULL
elevated	NULL
concentrations	NULL
of	NULL
E2A	NULL
proteins	NULL
leads	NULL
to	NULL
formation	NULL
of	NULL
the	NULL
homodimeric	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
LEFLI/BCF1	NULL
)	NULL
,	NULL
a	NULL
presumptive	NULL
lymphoid	NULL
cell	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
precise	NULL
mechanisms	NULL
mediating	NULL
the	NULL
preferential	NULL
accumulation	NULL
of	NULL
E2A	NULL
gene	NULL
products	NULL
in	NULL
lymphoid	NULL
cells	NULL
remain	NULL
to	NULL
be	NULL
established	NULL
.	NULL

ACKNOWLEDGEMENTS	NULL
We	NULL
thank	NULL
Dr	NULL
Y.Citri	NULL
and	NULL
C.W.Park	NULL
for	NULL
valuable	NULL
discussions	NULL
.	NULL

The	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Juvenile	NULL
Diabetes	NULL
Foundation	NULL
International	NULL
,	NULL
the	NULL
Israel	NULL
Academy	NULL
of	NULL
Sciences	NULL
and	NULL
Humanities	NULL
,	NULL
the	NULL
Henry	NULL
and	NULL
Francoise	NULL
Glasberg	NULL
Foundation	NULL
,	NULL
and	NULL
the	NULL
Forchheimer	NULL
Center	NULL
for	NULL
Molecular	NULL
Genetics	NULL
.	NULL

MDW	NULL
is	NULL
the	NULL
incumbent	NULL
of	NULL
the	NULL
Maurice	NULL
M.Bookstein	NULL
Career	NULL
Development	NULL
Chair	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Church	NULL
,	NULL
G.M	NULL
.	NULL

,	NULL
Tonegawa	NULL
,	NULL
S.	NULL
and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
.	NULL

227	NULL
,	NULL
134-138	NULL
.	NULL

2	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
.	NULL

236	NULL
,	NULL
1573-1577	NULL
.	NULL

3	NULL
.	NULL

Karlsson	NULL
,	NULL
O.	NULL
,	NULL
Edlund	NULL
,	NULL
T.	NULL
,	NULL
Moss	NULL
,	NULL
J.B.	NULL
,	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

(	NULL
USA	NULL
)	NULL
.	NULL

84	NULL
,	NULL
8819-8823	NULL
.	NULL

4	NULL
.	NULL

Lassar	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Buskin	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Lockshon	NULL
,	NULL
D.	NULL
,	NULL
Davis	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
Apone	NULL
,	NULL
S.	NULL
,	NULL
Hauschka	NULL
,	NULL
S.D	NULL
.	NULL

and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
.	NULL

58	NULL
,	NULL
823-831.	NULL
.	NULL

Meister	NULL
,	NULL
A.	NULL
,	NULL
Weinrich	NULL
,	NULL
S.L	NULL
.	NULL

,	NULL
Nelson	NULL
,	NULL
C.	NULL
and	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
20744-20751	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
.	NULL

56	NULL
,	NULL
777-783.	NULL
.	NULL

Blackwell	NULL
,	NULL
TK	NULL
.	NULL

and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
.	NULL

250	NULL
,	NULL
1104-1110.	NULL
.	NULL

Weintraub	NULL
,	NULL
H.	NULL
,	NULL
Davis	NULL
,	NULL
R.	NULL
,	NULL
Tapscott	NULL
,	NULL
S.	NULL
,	NULL
Thayer	NULL
,	NULL
M.	NULL
,	NULL
Krause	NULL
,	NULL
M.	NULL
,	NULL
Benezra	NULL
,	NULL
R.	NULL
,	NULL
Blackwell	NULL
,	NULL
TK	NULL
.	NULL

,	NULL
Turner	NULL
,	NULL
D.	NULL
,	NULL
Rupp	NULL
,	NULL
R.	NULL
,	NULL
Hollenberg	NULL
,	NULL
S.	NULL
,	NULL
Zhuang	NULL
,	NULL
Y.	NULL
and	NULL
Lassar	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Science	NULL
.	NULL

251	NULL
,	NULL
761-766	NULL
.	NULL

9	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
Kiledjian	NULL
,	NULL
M.	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
.	NULL

247	NULL
,	NULL
467-470	NULL
.	NULL

10	NULL
.	NULL

Sun	NULL
,	NULL
X.-H.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
.	NULL

64	NULL
,	NULL
459-470	NULL
.	NULL

11	NULL
.	NULL

Walker	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Park	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
Rosen	NULL
,	NULL
A.	NULL
and	NULL
Aronheim	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18	NULL
,	NULL
1159-1166	NULL
.	NULL

12	NULL
.	NULL

German	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
Blanar	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Nelson	NULL
,	NULL
C.	NULL
,	NULL
Moss	NULL
,	NULL
L.G	NULL
.	NULL

and	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Mol	NULL
Endocrinol	NULL
.	NULL

5	NULL
,	NULL
292-299	NULL
.	NULL

13	NULL
.	NULL

Nelson	NULL
,	NULL
C.	NULL
,	NULL
Shen	NULL
,	NULL
L.P.	NULL
,	NULL
Meister	NULL
,	NULL
A.	NULL
,	NULL
Fodor	NULL
,	NULL
E.	NULL
and	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1035-1043	NULL
.	NULL

14	NULL
.	NULL

Visvader	NULL
,	NULL
J.	NULL
,	NULL
Begley	NULL
,	NULL
C.G	NULL
.	NULL

and	NULL
Adams	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
.	NULL

6	NULL
,	NULL
187-194.	NULL
un	NULL
go	NULL
-t	NULL
}	NULL
on	NULL
26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37.	NULL
.	NULL

Laemmli	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1970	NULL
)	NULL
Nature	NULL
.	NULL

227	NULL
,	NULL
680-685	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

47	NULL
.	NULL

48.	NULL
.	NULL

Caudy	NULL
,	NULL
M.	NULL
,	NULL
Vassin	NULL
,	NULL
H.	NULL
,	NULL
Brand	NULL
,	NULL
M.	NULL
,	NULL
Tuma	NULL
,	NULL
R.	NULL
,	NULL
Jan	NULL
,	NULL
L.Y	NULL
.	NULL

and	NULL
Jan	NULL
,	NULL
Y.N	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
.	NULL

55	NULL
,	NULL
1061-1067.	NULL
.	NULL

Davis	NULL
,	NULL
R.L	NULL
.	NULL

,	NULL
Weintraub	NULL
,	NULL
H.	NULL
and	NULL
Lassar	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
.	NULL

51	NULL
,	NULL
987-1000.	NULL
.	NULL

Edmondson	NULL
,	NULL
D.G	NULL
.	NULL

and	NULL
Olson	NULL
,	NULL
E.N	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
and	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
628-640.	NULL
.	NULL

Wright	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Sassoon	NULL
,	NULL
D.A	NULL
.	NULL

and	NULL
Lin	NULL
,	NULL
V.K	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
.	NULL

56	NULL
,	NULL
607-617.	NULL
.	NULL

Braun	NULL
,	NULL
T.	NULL
,	NULL
Buschhausen	NULL
,	NULL
D.G	NULL
.	NULL

,	NULL
Bober	NULL
,	NULL
E.	NULL
,	NULL
Tannich	NULL
,	NULL
E.	NULL
and	NULL
Arnold	NULL
,	NULL
H.H	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
701-709.	NULL
.	NULL

Rhodes	NULL
,	NULL
S.J	NULL
.	NULL

and	NULL
Konieczny	NULL
,	NULL
S.F	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
2050-2061.	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
McCaw	NULL
,	NULL
P.S	NULL
.	NULL

,	NULL
Vaessin	NULL
,	NULL
H.	NULL
,	NULL
Caudy	NULL
,	NULL
M.	NULL
,	NULL
Jan	NULL
,	NULL
L.Y	NULL
.	NULL

,	NULL
Jan	NULL
,	NULL
Y.N	NULL
.	NULL

,	NULL
Cabrera	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
Buskin	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Hauschka	NULL
,	NULL
S.D	NULL
.	NULL

,	NULL
Lassar	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Weintraub	NULL
,	NULL
H.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
.	NULL

58	NULL
,	NULL
537-544.	NULL
.	NULL

Lassar	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Davis	NULL
,	NULL
RL	NULL
.	NULL

,	NULL
Wright	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Kadesch	NULL
,	NULL
T.	NULL
,	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
Voronova	NULL
,	NULL
A.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
and	NULL
Weintraub	NULL
,	NULL
H.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
.	NULL

66	NULL
,	NULL
305-315.	NULL
.	NULL

Karlsson	NULL
,	NULL
O.	NULL
,	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

and	NULL
Edlund	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
823-827.	NULL
.	NULL

Whelan	NULL
,	NULL
J.	NULL
,	NULL
Poon	NULL
,	NULL
D.	NULL
,	NULL
Weil	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Stein	NULL
,	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
3252-3259.	NULL
.	NULL

Ohlsson	NULL
,	NULL
H.	NULL
,	NULL
Karlsson	NULL
,	NULL
O.	NULL
and	NULL
Edlund	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

(	NULL
USA	NULL
)	NULL
.	NULL

85	NULL
,	NULL
4228-4231	NULL
.	NULL

Whelan	NULL
,	NULL
J.	NULL
,	NULL
Cordle	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Henderson	NULL
,	NULL
E.	NULL
,	NULL
Weil	NULL
,	NULL
P.	NULL
A.	NULL
and	NULL
Stein	NULL
,	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1564-1572	NULL
.	NULL

Aronheim	NULL
,	NULL
A.	NULL
,	NULL
Ohlsson	NULL
,	NULL
H.	NULL
,	NULL
Park	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
Edlund	NULL
,	NULL
T.	NULL
and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Nucl	NULL
.	NULL

Acids	NULL
.	NULL

Res	NULL
.	NULL

19	NULL
,	NULL
3893-3899	NULL
.	NULL

Cordle	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Henderson	NULL
,	NULL
E.	NULL
,	NULL
Masuoka	NULL
,	NULL
H.	NULL
,	NULL
Weil	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Stein	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1734-1738	NULL
.	NULL

Shieh	NULL
,	NULL
S.-Y	NULL
.	NULL

and	NULL
Tsai	NULL
,	NULL
M.-J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
16708-16714	NULL
.	NULL

Park	NULL
,	NULL
C.W	NULL
.	NULL

and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
15642-15649	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
Voronova	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
1156-1160	NULL
.	NULL

Voliva	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
Aronheim	NULL
,	NULL
A.	NULL
,	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

and	NULL
Peterlin	NULL
,	NULL
B.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
2383-2390	NULL
.	NULL

Shiran	NULL
,	NULL
R.	NULL
,	NULL
Aronheim	NULL
,	NULL
A.	NULL
,	NULL
Rosen	NULL
,	NULL
A.	NULL
,	NULL
Park	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
Leshkowitz	NULL
,	NULL
D.	NULL
and	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
.	NULL

(	NULL
in	NULL
press	NULL
)	NULL
.	NULL

Santerre	NULL
,	NULL
R.F	NULL
.	NULL

,	NULL
Cook	NULL
,	NULL
R.A.	NULL
,	NULL
Crisel	NULL
,	NULL
R.M.D	NULL
.	NULL

,	NULL
Sharp	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Schmidt	NULL
,	NULL
R.J.	NULL
,	NULL
Williams	NULL
,	NULL
D.C.	NULL
and	NULL
Wilson	NULL
,	NULL
C.P	NULL
.	NULL

(	NULL
1981	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

78	NULL
,	NULL
4339-4343	NULL
.	NULL

Edlund	NULL
,	NULL
T.	NULL
,	NULL
Walker	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Barr	NULL
,	NULL
P.J	NULL
.	NULL

and	NULL
Rutter	NULL
,	NULL
W.J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Science	NULL
.	NULL

230	NULL
,	NULL
912-916	NULL
.	NULL

Efrat	NULL
,	NULL
S.	NULL
,	NULL
Linde	NULL
,	NULL
S.	NULL
,	NULL
Kofod	NULL
,	NULL
H.	NULL
,	NULL
Spector	NULL
,	NULL
D.	NULL
,	NULL
Delannoy	NULL
,	NULL
M.	NULL
,	NULL
Grant	NULL
,	NULL
S.	NULL
,	NULL
Hanahan	NULL
,	NULL
D.	NULL
and	NULL
Baekkeskov	NULL
,	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
(	NULL
USA	NULL
)	NULL
.	NULL

85	NULL
,	NULL
9037-9041	NULL
.	NULL

Dieckmann	NULL
,	NULL
C.L	NULL
.	NULL

and	NULL
Tzagaloff	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

260	NULL
,	NULL
1513-1520	NULL
.	NULL

Aronheim	NULL
,	NULL
A.	NULL
,	NULL
Eshel	NULL
,	NULL
Y.	NULL
,	NULL
Mosckovitz	NULL
,	NULL
R.	NULL
and	NULL
Gershoni	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263	NULL
,	NULL
9933-9937.	NULL
.	NULL

Lowry	NULL
,	NULL
O.H	NULL
.	NULL

,	NULL
Rosebrough	NULL
,	NULL
N.J.	NULL
,	NULL
Farr	NULL
,	NULL
A.L	NULL
.	NULL

and	NULL
Randall	NULL
,	NULL
R.J.	NULL
(	NULL
1951	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

193	NULL
,	NULL
265-275	NULL
.	NULL

Wigler	NULL
,	NULL
M.	NULL
,	NULL
Pellicer	NULL
,	NULL
A.	NULL
,	NULL
Silverstein	NULL
,	NULL
S.	NULL
,	NULL
Axel	NULL
,	NULL
R.	NULL
,	NULL
Urlaub	NULL
,	NULL
G.	NULL
and	NULL
Chasin	NULL
,	NULL
L.	NULL
(	NULL
1979	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

(	NULL
USA	NULL
)	NULL
.	NULL

76	NULL
,	NULL
1373-1376	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.M	NULL
.	NULL

and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

Kamps	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Murre	NULL
,	NULL
C.	NULL
,	NULL
Sun	NULL
,	NULL
X.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
.	NULL

60	NULL
,	NULL
547-555.	NULL
.	NULL

Wilson	NULL
,	NULL
R.B	NULL
.	NULL

,	NULL
Kiledjian	NULL
,	NULL
M.	NULL
,	NULL
Shen	NULL
,	NULL
C.P	NULL
.	NULL

,	NULL
Benezra	NULL
,	NULL
R.	NULL
,	NULL
Zwollo	NULL
,	NULL
P.	NULL
,	NULL
Dymecki	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Desiderio	NULL
,	NULL
S.V	NULL
.	NULL

and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
Cell	NULL
Biol	NULL
.	NULL

11	NULL
,	NULL
6185-6191	NULL
.	NULL

Church	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Gilbert	NULL
,	NULL
W.	NULL
and	NULL
Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
.	NULL

313	NULL
,	NULL
798-801.	NULL
.	NULL

Hu	NULL
,	NULL
J.-H.	NULL
,	NULL
Olson	NULL
,	NULL
E.N	NULL
.	NULL

and	NULL
Kingston	NULL
,	NULL
R.E	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1031-1042	NULL
.	NULL

Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
.	NULL

13	NULL
,	NULL
31-36	NULL
.	NULL

Schlissel	NULL
,	NULL
M.	NULL
,	NULL
Voronova	NULL
,	NULL
A.	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
&	NULL
Development	NULL
.	NULL

5	NULL
,	NULL
1367-1376	NULL
.	NULL

